1. hnRNPK-derived cell-penetrating peptide inhibits cancer cell survival
   Pavan Kumar Puvvula et al, 2021, Molecular Therapy - Oncolytics CrossRef
2. Drug delivery approaches for HuR-targeted therapy for lung cancer
   Rajeswari Raguraman et al, 2022, Advanced Drug Delivery Reviews CrossRef
3. Keratin 19 regulates cell cycle pathway and sensitivity of breast cancer cells to CDK inhibitors
   Pooja Sharma et al, 2019, Scientific Reports CrossRef
4. The Eµ-hnRNP K Murine Model of Lymphoma: Novel Insights into the Role of hnRNP K in B-Cell Malignancies
   Prerna Malaney et al, 2021, Frontiers in Immunology CrossRef
5. hnRNP K induces HPV16 oncogene expression and promotes cervical cancerization
   Yuanjing Lyu et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
6. Deregulation of splicing factors and breast cancer development
   Marco Silipo et al, 2015, Journal of Molecular Cell Biology CrossRef
7. The emerging roles of hnRNPK
   Ziyi Wang et al, 2020, Journal of Cellular Physiology CrossRef
8. The Role of RNA-Binding Proteins in Hematological Malignancies
   Pedro Aguilar-Garrido et al, 2022, International Journal of Molecular Sciences CrossRef
9. RNA packaging into extracellular vesicles: An orchestra of RNA‐binding proteins?
   Fabrizio Fabbiano et al, 2020, Journal of Extracellular Vesicles CrossRef
10. Effect of Derris�scandens extract on a human hepatocellular carcinoma cell line
    Duanghathai Kuljittichanok et al, 2018, Oncology Letters CrossRef
11. Screening and Identification of Novel Potential Biomarkers for Breast Cancer Brain Metastases
    Lulu Wang et al, 2022, Frontiers in Oncology CrossRef
12. MYU, a Target lncRNA for Wnt/c-Myc Signaling, Mediates Induction of CDK6 to Promote Cell Cycle Progression
    Yoshihiro Kawasaki et al, 2016, Cell Reports CrossRef
13. hnRNP K Coordinates Transcriptional Silencing by SETDB1 in Embryonic Stem Cells
    Peter J. Thompson et al, 2015, PLOS Genetics CrossRef
14. DNA-methylation-induced silencing of DIO3OS drives non-small cell lung cancer progression via activating hnRNPK-MYC-CDC25A axis
    Meichun Zhang et al, 2021, Molecular Therapy - Oncolytics CrossRef